Home

Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy

Salim Abdool Karim; Kogieleum Naidoo; Anneke C. Grobler; Nesri Padayatchi; Cheryl Baxter; Andrew L. Gray; Tanuja N. Gengiah; Gonasagrie Nair; Sheila Bamber; Aarthi Singh; Munira Khan; Jacqueline Pienaar; Wafaa Mahmoud El-Sadr; Gerald Friedland; Quarraisha Abdool Karim

Title:
Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
Author(s):
Abdool Karim, Salim
Naidoo, Kogieleum
Grobler, Anneke C.
Padayatchi, Nesri
Baxter, Cheryl
Gray, Andrew L.
Gengiah, Tanuja N.
Nair, Gonasagrie
Bamber, Sheila
Singh, Aarthi
Khan, Munira
Pienaar, Jacqueline
El-Sadr, Wafaa Mahmoud
Friedland, Gerald
Abdool Karim, Quarraisha
Date:
Type:
Articles
Department:
Epidemiology
Volume:
362
Permanent URL:
Book/Journal Title:
New England Journal of Medicine
Abstract:
The rates of death are high among patients with coinfection with tuberculosis and the human immunodeficiency virus (HIV). The optimal timing for the initiation of antiretroviral therapy in relation to tuberculosis therapy remains controversial.
Subject(s):
Virology
Epidemiology
Publisher DOI:
http://dx.doi.org/10.1056/NEJMoa0905848
Item views:
308
Metadata:
text | xml

In Partnership with the Center for Digital Research and Scholarship at Columbia University Libraries/Information Services | Terms of Use